article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

In trials, the Glucommander algorithm has been shown to reduce severe low blood sugar episodes, shorten hospital stays and prevent hospital re-admissions. The post Roche debuts smart glucose monitor for hospital use appeared first on.

Hospitals 128
article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology.

Hospitals 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 804: Faster Amiodarone is Better For Survival in Shock-Refractory Out-of-Hospital Cardiac Arrest

Pharmacy Joe

In this episode, I’ll discuss an article about timing of amiodarone for out-of-hospital, shock-refractory cardiac arrest. In the early group, patients who received amiodarone has statistically signficantly higher rates of survival to hospital admission, survival to discharge, and functional survival when compared to placebo.

Hospitals 105
article thumbnail

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money

Drug Channels

Hospitals accounted for 87% of these skyrocketing 340B purchases. Read on for full details and analysis, including the opportunity to download your very own copy of the raw data from HRSA. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9

article thumbnail

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money (rerun)

Drug Channels

Hospitals accounted for 87% of these skyrocketing 340B purchases. Read on for full details and analysis, including the opportunity to download your very own copy of the raw data from HRSA. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9

article thumbnail

Episode 928: What is the best vasopressor to use in post-resuscitation shock?

Pharmacy Joe

Nearly 800 patients at 5 hospitals were included in the analysis. The primary outcome was all-cause in-hospital mortality, and secondary outcomes were cardiovascular in-hospital mortality and unfavorable neurological outcome. Furthermore, the odds ratio for cardiovascular in-hospital mortality was 5.5 for epinephrine.

article thumbnail

EM Match Advice 41: The 2024 ERAS Application – New and Improved

ALiEM - Pharm Pearls

Sara Krzyzaniak (EM program director at Stanford) hosts this episode with Dr. Michelle Lin (ALiEM/UCSF) featuring all-star guests Dr. Alexis Pelletier-Bui (EM associate program director at Cooper University Hospital) and Dr. Elizabeth Werley (EM program director at Penn State Hershey).

Hospitals 130